Home › Non-Small Cell Lung Cancer › California › Mountain View
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Mountain View, CA
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Mountain View. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi ang layo
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi ang layo
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi ang layo
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
Nagre-recruitPhase 3
- Stanford University, Stanford · 5 mi ang layo
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Nagre-recruitPhase 2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
- Stanford University, Palo Alto · 5 mi ang layo
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Nagre-recruitPhase 2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
- Stanford Hospital and Clinics, Stanford · 5 mi ang layo
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi ang layo
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Stanford Cancer Center, Palo Alto · 5 mi ang layo
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
- Stanford University Medical Center - Neurology, Stanford · 5 mi ang layo
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi ang layo
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Nagre-recruitPhase 1/2
- Stanford University Medical Center, Stanford · 5 mi ang layo
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Nagre-recruitPhase 1
- Stanford University Medical Center, Palo Alto · 5 mi ang layo
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Nagre-recruitPhase 1
- Stanford University, Palo Alto · 5 mi ang layo
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Nagre-recruitPhase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi ang layo
A Study of LY4175408 in Participants With Advanced Cancer
Nagre-recruitPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi ang layo
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Stanford University, Stanford · 5 mi ang layo
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Nagre-recruitPhase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi ang layo
Engagement of Veterans With Lung Cancer
Nagre-recruit
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Stanford · 5 mi ang layo
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1
- Stanford University, Stanford · 5 mi ang layo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Mountain View
- Kanser (lahat ng uri)40 pag-aaral
- Kanser sa Suso26 pag-aaral
- Metastatic Cancer25 pag-aaral
- Acute Myeloid Leukemia19 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Autism Spectrum Disorder17 pag-aaral
- Kanser sa Baga17 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Pagkabigo ng Puso15 pag-aaral
- Autism13 pag-aaral
- Acute Lymphoblastic Leukemia13 pag-aaral
- Colorectal Cancer13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.